MangoceuticalsMGRX
13F holders, Q2 2025 (June 30)10holders +2
3new positions
1sold out
1famous investor
$1.52avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, up 2 from Q1 2025. 3 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($278K), Ackerman Capital Advisors, LLC ($52K) and Renaissance Technologies ($47K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $341K |
| Exits | 1 | $14K |
All 13F filers, Q1 2025 → Q2 2025: 231,466 shares bought and 14,531 shares sold, net +216,935 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Vanguard Group Inc. | 0.00% | New | 182,613 | $278K |
| Ackerman Capital Advisors, LLC | 0.01% | No change | 34,500 | $52K |
| Renaissance Technologies | 0.00% | New | 31,000 | $47K |
| Geode Capital Management, LLC | 0.00% | Add +35.4% | 26,498 | $40K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,570 | $16K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,885 | $4K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,094 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +12.6% | 1,850 | $3K |
| Bank of America Corp. | 0.00% | Add +986.7% | 163 | $247 |
| UBS Group AG | 0.00% | Reduce -99.0% | 79 | $120 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.